MedTrace Logo

A Technology Assisted Care Transition Intervention for Veterans With CHF or COPD

NCT02632552 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2023-07-27

Study results available
· View outcomes & findings →

Summary

Transition from hospital to home places patients in jeopardy of adverse events and increases their risk for rehospitalization. CHF is the most prevalent chronic condition among U.S. adults and COPD is the third leading cause of death in the U.S. Both CHF and COPD represent significant burdens for the VHA healthcare system. Care transitions can be supported through multi-component interventions, but are costly to implement. Virtual nurses provide an effective medium for explaining health concepts to patients, and previous work indicates patients find virtual nurses acceptable. The investigators will implement and evaluate a virtual nurse intervention to provide automated, tailored, and timely support to Veterans transitioning from hospital to home. As effective care transition interventions incorporate both inpatient and outpatient components, the virtual nurse will first engage with patient onscreen during their inpatient stay and then via text message post-discharge. This project has the potential to improve the care transition experience for patients, caregivers and healthcare providers.

Conditions

Interventions

BEHAVIORAL

Technology-assisted care transition intervention

In-patient virtual nurse on-screen touchscreen and outpatient virtual nurse follow-up by texting

BEHAVIORAL

Active attention control

In-patient brief animated power-point style didactic onscreen tutorial covering the core pillars of care transitions and brief outpatient texting

Sponsors & Collaborators

  • Northeastern University

    collaborator OTHER

  • VA Office of Research and Development

    lead FED

Principal Investigators

  • Timothy Patrick Hogan, PhD MS BS · VA Bedford HealthCare System, Bedford, MA

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-01
Primary Completion
2020-06-30
Completion
2021-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02632552 on ClinicalTrials.gov